Thursday, 22 March 2012

Immunotherapy and cancer

Researchers at the Georgetown Lombardi comprehensive cancer centre say that antibodies which were once considered the 'magic bullets' of cancer treatment are now living up to that expectation.

In an article posted in 'Cell' the researchers say that refinements and modifications of monoclonal antibody drugs are now being tested in most types of tumour. The modifications allow the drugs to attach to more than one target on the cell and to directly stimulate the body's immune response which promotes anti-tumour effects similar to a vaccine. In addition to this some antibodies will lock onto the antigens on the surface of a cancer cell and then a chemical attached to to them will emit beta radiation. This type of radiation emits radiation with a radius of a couple of centimetres so it can destroy an entire tumour but with little collateral damage to the normal surrounding tissue.

After doing some work on this subject in Human Biology I became quite interested in immunotherapy as it is using the body's own natural defences to fight something that is more difficult to attack with artificial means such as chemotherapy and radiotherapy. This is something that I would quite like to do some research into because I think it has the best possibility of leading to a full cure for cancer. One of the drawbacks of this treatment is that the antigens which are needed for it to work are only present on the surfaces of some types of cancer cells, meaning it is only an option in a fraction of cases. However, if that can be worked around, it will be a lot more effective as a treatment and more research into it will be done.

Jack

No comments:

Post a Comment